Green Cross Health Ltd · NZX:GXH
Green Cross Health — H1 FY2024 Earnings Presentation
20 slides from Green Cross Health's earnings presentation, Nov 29, 2023
Slide 1: Half Year Results Presentation
GREEN CROSS HEALTH Half Year Results Presentation Unichem? Life-© @pinrop GREEN - thedoctors House HEALTH
Slide 2: Disclaimer
Disclaimer The information in this presentation was prepared by Green Cross Health Limited (GXH) with due care and attention. However, the information is supplied in summary form and is therefore not necessarily complete, and no representation is made as to the accuracy, completeness or reliability
Slide 3: Operational Highlights
Operational Highlights Group • $2.2m increase in Group Revenue year-on-year • Significant investment in IT infrastructure; ERP Highlights upgrade completed and product information system replaced Pharmacy • Total prescriptions up 3.3% on same-store basis • $5 co-payment removal Division • 295,961 fl
Slide 4: GXH Interim Result - Financial Overview
GXH Interim Result - Financial Overview Group Performance Divisional Performance Group Revenue Pharmacy Operating Profit (EBIT) $250.2m $8.7m 1% increase vs 1H23 25% decrease vs 1H23 Operating Profit (EBIT) Medical Operating Profit (EBIT) $14.9m $7.3m 17% decrease vs 1H23 21% decrease vs 1H23 Net Pr
Slide 5: Pharmacy Division
Pharmacy Division New Zealand’s largest network of health retailers: supporting easy access to quality health care
Slide 6: Pharmacy Performance
Pharmacy Performance Pharmacy Revenue ($m) 180 182 • Revenue of $182m 170 • Operating Profit (EBIT) at $8.7m 154 • Diminished levels of higher-margin COVID-19 activity and increased 1H21 1H22 1H23 1H24 labour costs resulted in Operating Profit (EBIT) down 25% Pharmacy Operating Profit/EBIT ($m) • Sa
Slide 7: Operational Highlights - Pharmacy
Operational Highlights - Pharmacy Flu Vaccines and Total Scripts 350 20 Continued growth in influenza vaccination volumes, up 3.3% on 1H23 300 19 Initial scripts up 5.9% vs. 1H23 for same 18 250 stores Total Network Scripts (m) 17 Flu Vaccines (000's) Increase in loyalty membership to 1.99m 200 175
Slide 8: Pharmacy Will Win By Focusing on the Customer
Pharmacy Will Win By Focusing on the Customer Workforce productivity Differentiated brand and & occupancy cost products, recognising control Brand & customer loyalty Cost focus customer Leveraging our trusted Professional instore brands, advocating for equity Network scale & Retail experience, margi
Slide 9: Medical Division
Medical Division Growth, leadership and sustainable models of care
Slide 10: Medical Performance
Medical Performance Medical Revenue ($m) 68 69 Revenue up 1% to $69m 46 Diminished levels of COVID-19 41 activity and increased labour costs resulted in Operating Profit (EBIT) down 21% to $7.3m 1H21 1H22 1H23 1H24 Review of cost base to minimise Medical Operating Profit/EBIT ($m) impact of labour s
Slide 11: Operational Highlights - Medical
Operational Highlights - Medical The Doctors App Successful completion of three 25 35 acquisitions to end period with 63 30 Registered Users (‘000) 20 25 Medical Centres medical centres. Two further acquisitions 15 20 completed post Sep-23 10 15 Strong pipeline of future acquisitions 10 5 5 HouseCal
Slide 12: Medical Strategy of Organic Growth & Acquisitions
Medical Strategy of Organic Growth & Acquisitions Workforce productivity High quality patient care & margin management Cost & margin Patient & focus Brand Continuous improvement Targeted centre focus, clinical development acquisitions Operational Scale improvement Technology Utilising data and syste
Slide 13: Group Financial Result
Group Financial Result 6 months ending 30 September 2023 GXH Half Year Results Presentation 29 November 2023 Pg 13
Slide 14: Group Revenue and Operating Profit (EBIT)
Group Revenue and Operating Profit (EBIT) Revenue From Continuing Operations ($m) Operating Profit (EBIT) From Continuing Operations ($m) 17.8 18.1 16.1 14.9 248 250 216 195 1H21 1H22 1H23 1H24 1H21 1H22 1H23 1H24 • Revenue of $250m, up 1% vs 1H23 Operating Profit (EBIT) from continuing • Fourth con
Slide 15: Group NPAT, EPS & Dividend
Group NPAT, EPS & Dividend Net Profit After Tax Attributable to Shareholders From Continuing Operations ($m) • Net Profit After Tax Attributable to Shareholders down 21% on a continuing 7.7 7.8 operations basis 7.1 5.6 • EPS at 3.91 cps, a decrease of 1 cent • Interim dividend of 2.5 cps ($3.6m) dec
Slide 16: Working Capital and Operating Cash Flow
Working Capital and Operating Cash Flow Gearing Ratio (debt / debt + equity) GXH Operating Cash Flow ($m) 39.1 22.1% 28.9 16.2% 14.3% 12.4% 17.8 18.8 1H21 1H22 1H23 1H24 1H21 1H22 1H23 1H24 • Gearing ratio of 16.2% as at 30 September 2023 • Operating Cash Flow of $18.8m • Robust working capital mana
Slide 17: Outlook
Outlook ➢ Challenging retail environment, labour cost pressures and funding shortfalls continue in short-term ➢ Maximising labour efficiency and management of costs a priority ➢ Focus remains on sustained earnings growth through acquisition and investment in new product and service offerings ➢ Earni
Slide 18: About Green Cross Health
About Green Cross Health GXH Half Year Results Presentation 29 November 2023 Pg 18
Slide 19: Our Purpose
Our Purpose Working together to support healthier communities. We are passionately committed to the health and wellness of New Zealand, and to providing the best support, care and advice to our communities. This is our promise. GXH Half Year Results Presentation 29 November 2023 Pg 19
Slide 20: Who We Are
Who We Are GXH Half Year Results Presentation 29 November 2023 Pg 20